Literature DB >> 20926697

Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle.

Gareth J Jones1, Chris Pirson, R Glyn Hewinson, H Martin Vordermeier.   

Abstract

In order to identify cytokines that may be useful as candidates for inclusion in diagnostic tests for Mycobacterium bovis infection in cattle, we compared the levels of gamma interferon (IFN-γ), interleukin 1β (IL-1β), IL-4, IL-10, IL-12, macrophage inflammatory protein 1β (MIP-1β), and tumor necrosis factor alpha (TNF-α) in whole-blood cultures from tuberculosis (TB) reactor animals or TB-free controls following stimulation with M. bovis-specific antigens (purified protein derivative from M. bovis [PPD-B] or ESAT-6/CFP-10). In addition to IFN-γ responses, the production of IL-1β and TNF-α was also statistically significantly elevated in TB reactor cattle over that in uninfected controls following stimulation with PPD-B or ESAT-6/CFP-10 peptides. Thus, we evaluated whether the use of these two additional readouts could disclose further animals not detected by measuring IFN-γ alone. To this end, receiver operating characteristic (ROC) analyses were performed to define diagnostic cutoffs for positivity for TNF-α and IL-1β. These results revealed that for ESAT-6/CFP-10-induced responses, the use of all three readouts (IFN-γ, TNF-α, and IL-1β) in parallel increased the sensitivity of detection of M. bovis-infected animals by 11% but also resulted in a specificity decrease of 14%. However, applying only IFN-γ and IL-1β in parallel resulted in a 5% increase in sensitivity without the corresponding loss of specificity. The results for PPD-B-induced responses were similar, although the loss of specificity was more pronounced, even when only IFN-γ and IL-1β were used as readout systems. In conclusion, we have demonstrated that the use of an additional readout system, such as IL-1β, can potentially complement IFN-γ by increasing overall test sensitivity for the detection of M. bovis infection in cattle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926697      PMCID: PMC3008179          DOI: 10.1128/CVI.00377-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  26 in total

1.  Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle.

Authors:  H M Vordermeier; A Whelan; P J Cockle; L Farrant; N Palmer; R G Hewinson
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 2.  The role of T-cell subsets in Mycobacterium tuberculosis infection.

Authors:  W H Boom
Journal:  Infect Agents Dis       Date:  1996-03

3.  Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production.

Authors:  Seth L Masters; Lisa A Mielke; Ann L Cornish; Caroline E Sutton; Joanne O'Donnell; Louise H Cengia; Andrew W Roberts; Ian P Wicks; Kingston H G Mills; Ben A Croker
Journal:  EMBO Rep       Date:  2010-07-02       Impact factor: 8.807

4.  Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis.

Authors:  R Hernandez-Pando; H Orozco; K Arriaga; A Sampieri; J Larriva-Sahd; V Madrid-Marina
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

5.  Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot.

Authors:  R S Wallis; M Amir-Tahmasseb; J J Ellner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 6.  Mycobacterium bovis infection in human beings.

Authors:  J M Grange
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

Review 7.  BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis.

Authors:  P R Wood; S L Jones
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

8.  Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis.

Authors:  N P Juffermans; S Florquin; L Camoglio; A Verbon; A H Kolk; P Speelman; S J van Deventer; T van Der Poll
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

9.  Diagnostic implications of antigen-induced gamma interferon, nitric oxide, and tumor necrosis factor alpha production by peripheral blood mononuclear cells from Mycobacterium bovis-infected cattle.

Authors:  W R Waters; M V Palmer; D L Whipple; M P Carlson; B J Nonnecke
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  12 in total

1.  Use of antigen-specific interleukin-2 to differentiate between cattle vaccinated with Mycobacterium bovis BCG and cattle infected with M. bovis.

Authors:  Shelley G Rhodes; Lucy C McKinna; Sabine Steinbach; Gilly S Dean; Bernardo Villarreal-Ramos; Adam O Whelan; C Pirson; Gareth J Jones; Derek Clifford; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

2.  Role of QuantiFERON-TB Gold antigen-specific IL-1β in diagnosis of active tuberculosis.

Authors:  Maddineni Prabhavathi; Basirudeen Syed Ahamed Kabeer; Anbarasu Deenadayalan; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2014-12-11       Impact factor: 3.402

3.  Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle.

Authors:  Gareth J Jones; Sabine Steinbach; Derek Clifford; Susan L Baldwin; Gregory C Ireton; Rhea N Coler; Steven G Reed; H Martin Vordermeier
Journal:  Vaccine       Date:  2013-09-05       Impact factor: 3.641

4.  Evaluation of gamma interferon (IFN-γ)-induced protein 10 responses for detection of cattle infected with Mycobacterium bovis: comparisons to IFN-γ responses.

Authors:  W R Waters; T C Thacker; B J Nonnecke; M V Palmer; I Schiller; B Oesch; H M Vordermeier; E Silva; D M Estes
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

5.  Immune responses of bison and efficacy after booster vaccination with Brucella abortus strain RB51.

Authors:  S C Olsen; J L McGill; R E Sacco; S G Hennager
Journal:  Clin Vaccine Immunol       Date:  2015-02-11

6.  Interleukin-17A as a Biomarker for Bovine Tuberculosis.

Authors:  W Ray Waters; Mayara F Maggioli; Mitchell V Palmer; Tyler C Thacker; Jodi L McGill; H Martin Vordermeier; Linda Berney-Meyer; William R Jacobs; Michelle H Larsen
Journal:  Clin Vaccine Immunol       Date:  2015-12-16

7.  Differential effects of Mycobacterium bovis--derived polar and apolar lipid fractions on bovine innate immune cells.

Authors:  Chris Pirson; Gareth J Jones; Sabine Steinbach; Gurdyal S Besra; H Martin Vordermeier
Journal:  Vet Res       Date:  2012-06-27       Impact factor: 3.683

8.  Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers.

Authors:  Elihu Aranday-Cortes; Philip J Hogarth; Daryan A Kaveh; Adam O Whelan; Bernardo Villarreal-Ramos; Ajit Lalvani; H Martin Vordermeier
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area.

Authors:  Novel N Chegou; Paulin N Essone; Andre G Loxton; Kim Stanley; Gillian F Black; Gian D van der Spuy; Paul D van Helden; Kees L Franken; Shreemanta K Parida; Michel R Klein; Stefan H E Kaufmann; Tom H M Ottenhoff; Gerhard Walzl
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

10.  Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.

Authors:  Novel N Chegou; Anne K Detjen; Lani Thiart; Elisabetta Walters; Anna M Mandalakas; Anneke C Hesseling; Gerhard Walzl
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.